Administration of valproic acid decreases oral clearance of temozolomide by about 5%. The clinical implication of this effect is not known. Patients with Severe Hepatic or Renal Impairment Caution should be exercised when TEMODAR Capsules are administered to patients with severe hepatic or renal impairment.